Inhibrx Biosciences Inc. (INBX)
NASDAQ·Healthcare·Biotechnology
$84.83
+0.36%
Mkt Cap $1.06B
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$285.00
Range $245.00 – $325.00
Implied Upside
+236.0%
Consensus $285.00 vs current $84.83
NASDAQ·Healthcare·Biotechnology
$84.83
+0.36%
Mkt Cap $1.06B
No recent rating data.
Price Target (2 analysts)
$285.00
Range $245.00 – $325.00
+236.0%
Consensus $285.00 vs current $84.83